A detailed history of Parkworth Wealth Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 20 shares of BMY stock, worth $1,110. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Holding current value
$1,110
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$51.92 - $59.94 $1,038 - $1,198
20 New
20 $1.13 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parkworth Wealth Management, Inc. Portfolio

Follow Parkworth Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkworth Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parkworth Wealth Management, Inc. with notifications on news.